Table 5.

Belief items with significant (p < 0.01) one-way analysis procedures and at least one significant post hoc test by average number of patients with type 2 diabetes seen per week

	Average number of patients with type 2 diabetes seen per week, mean score (SD)
	10–25 (n = 172)	26–59 (n = 221)	60–99 (n = 60)	≥ 100 (n = 52)	p-value (ANOVA)
I believe…
…for most of my patients, the fear of side effects (hypoglycaemia and/or weight gain) is the greatest barrier to their acceptance of insulin therapy	2.6 (0.9)	2.8 (1.0)	2.9 (1.1)	3.3*,† (1.0)	< 0.001
…the risk of weight gain associated with insulin therapy makes me reluctant to prescribe it for most of my patients with BMI ≥ 35	2.7 (1.0)	2.6 (1.0)	2.9 (1.0)	3.2† (1.0)	0.001
…the follow-up needed for most of my patients on insulin is too resource-intensive for my staff	2.6 (0.9)	2.6 (1.0)	2.8 (1.0)	3.2† (1.1)	0.001
…training in the proper administration and usage of insulin is too complicated for most patients	2.5 (0.8)	2.5 (0.9)	2.8 (1.0)	3.0*,† (1.0)	< 0.001
…most of my patients on oral diabetes therapy would be less adherent with insulin therapy	2.7 (0.8)	2.8 (0.9)	2.9 (0.9)	3.2* (0.9)	0.002

BMI, body mass index.

^*100 or more patients are significantly different from 10 to 25 patients.

^†100 or more patients are significantly different from 26 to 59 patients.